Search results summary
From Health Canada
Search criteria
- Status: Select all
- AIG: 0116900002
Search results
Status | DIN | Company | Product | Class | PM See footnote1 | Schedule | # See footnote2 | A.I. name See footnote3 | Strength |
---|---|---|---|---|---|---|---|---|---|
Marketed | 00886955 | FRESENIUS KABI CANADA LTD | CEFTAZIDIME FOR INJECTION, USP | Human | Yes | Prescription | 1 | CEFTAZIDIME | 2 G / VIAL |
Cancelled Post Market | 01974416 | GLAXO CANADA INC | CEPTAZ INJ 2GM/VIAL | Human | No | Prescription | 1 | CEFTAZIDIME | 2 G / VIAL |
Cancelled Post Market | 02215020 | GLAXOSMITHKLINE INC | CEPTAZ INJECTION - PWS IV 2GM/VIAL | Human | No | Prescription | 1 | CEFTAZIDIME | 2 G / VIAL |
Cancelled Post Market | 01980645 | ELI LILLY CANADA INC | TAZIDIME ADD-VANTAGE INJ 2GM/VIAL | Human | No | Prescription | 1 | CEFTAZIDIME | 2 G / VIAL |
Application information
Related information
Contact us
Version 4.0.3